← Back to Patent Explorer
US4623650A Expired / Lapsed US ⏱️ 0.0 years remaining

Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids

Assignee: Pfizer Inc
•
Filing: 1984-12-06
•
Granted: 1986-11-18
•
Expires: 2004-12-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-Substituted-6-fluoro-7-aryl-(8-fluoro)-1,4-dihydroquinol-4-one 3-carboxylic acids having antibacterial activity are prepared by reacting the corresponding alkyl 1-substituted-6-fluoro-7-bromo-(8-fluoro)-1,4-dihydroquinol-4-one-3-ca rboxylate with an arylmetallic compound and hydrolyzing the ester formed.

Inventors

  • 👤 Paul J. Gilligan
  • 👤 Paul R. McGuirk
  • 👤 Michael J. Witty

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 22:10
CPC Classifications
C; C07; C07D; C07D405/00; C07D405/02; C07D405/04; C07D215/00; C07D215/02; C07D215/16; C07D215/48; C07D215/54; C07D215/56; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/18; C07F7/1804

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 109 words
A compound selected from those of the formula: ##STR19## wherein R 1 is hydrogen, alkyl of 1 to 6 carbon atoms, benzyl or a pharmaceutically acceptable cation; R 2 is hydrogen or fluoro; Y is alkyl, haloalkyl or polyhaloalkyl of 1 to 3 carbon atoms, hydroxyethyl, cyclopropyl, vinyl, allkyl, phenyl, 4-hydroxyphenyl or 4-fluorophenyl; R' is hydrogen, alkylsulfinyl or alkylsulfonyl of 1 to 4 carbon atoms, hydroxy, hydroxyalkyl of 1 to 3 carbon atoms, amino, aminoalkyl of 1 to 3 carbon atoms, formamido, alkanoylamino of 2 or 3 carbon atoms, aminosulfonyl, nitro, formyl, N-(N',N'-dimethylformamidino); and R" is hydrogen, 3-hydroxy or 3-chloro; provided that R' and R" are not both hydrogen.
Claim 2
Dependent Claim 109 words
A compound selected from those of the formula: ##STR19## wherein R 1 is hydrogen, alkyl of 1 to 6 carbon atoms, benzyl or a pharmaceutically acceptable cation; R 2 is hydrogen or fluoro; Y is alkyl, haloalkyl or polyhaloalkyl of 1 to 3 carbon atoms, hydroxyethyl, cyclopropyl, vinyl, allkyl, phenyl, 4-hydroxyphenyl or 4-fluorophenyl; R' is hydrogen, alkylsulfinyl or alkylsulfonyl of 1 to 4 carbon atoms, hydroxy, hydroxyalkyl of 1 to 3 carbon atoms, amino, aminoalkyl of 1 to 3 carbon atoms, formamido, alkanoylamino of 2 or 3 carbon atoms, aminosulfonyl, nitro, formyl, N-(N',N'-dimethylformamidino); and R" is hydrogen, 3-hydroxy or 3-chloro; provided that R' and R" are not both hydrogen.
Claim 3
Dependent Claim 17 words
A compound as claimed in claim 1 wherein R 1 is hydrogen or a pharmaceutically acceptable cation.
Claim 4
Dependent Claim 11 words
A compound as claimed in claim 2 wherein Y is ethyl.
Claim 5
Dependent Claim 12 words
A compound as claimed in claim 3 wherein R 2 is fluorine.
Claim 6
Dependent Claim 51 words
A compound as claimed in claim 4 wherein said compound is selected from the group consisting of 6,8-difluoro-7-(4-hydroxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-chloro-4-hydroxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-hydroxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-aminomethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-aminomethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-methylsulfinylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-methylsulfonylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-methoxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid and 6,8-difluoro-7-(3-hydroxymethyl-4-hydroxy)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid.
Claim 7
Dependent Claim 12 words
A compound as claimed in claim 3 wherein R 2 is hydrogen.
Claim 8
Dependent Claim 45 words
A compound as claimed in claim 6 wherein said compound is selected from the group consisting of 6-fluoro-7-(4-aminophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-nitrophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-formamidophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-acetamidophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-N-(N',N'-dimethylformamidino)phenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-formylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(3-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid and 6-fluoro-7-(4-aminosulfonylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid.
Claim 9
Dependent Claim 13 words
A compound as claimed in claim 1 wherein said compound is 9-fluoro-10-(4-aminosulfonylphenyl)-3-methyl-7oxo-2,3-dihydro-(7H)-pyrido-(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid.
Claim 10
Dependent Claim 26 words
An antibacterial composition comprising a compound as claimed in claim 1 in an amount sufficient for treament of a bacterial disease and a pharmaceutically acceptable carrier.
Claim 11
Dependent Claim 51 words
A composition as claimed in claim 9 wherein said compound is selected from the group consisting of 6,8-difluoro-7-(4-hydroxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-chloro-4-hydroxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-hydroxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-aminomethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-aminomethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-methylsulfinylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(3-methylsulfonylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6,8-difluoro-7-(4-methoxyphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid and 6,8-difluoro-7-(3-hydroxymethyl-4-hydroxy)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid.
Claim 12
Dependent Claim 45 words
A composition as claimed in claim 9 wherein said compound is selected from the group consisting of 6-fluoro-7-(4-aminophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-nitrophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-formamidophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-acetamidophenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-N-(N',N'-dimethylformamidino)phenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-formylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(4-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid 6-fluoro-7-(3-hydroxymethylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid and 6-fluoro-7-(4-aminosulfonylphenyl)-1-ethyl-1,4-dihydroquinol-4-one 3-carboxylic acid.
Claim 13
Dependent Claim 13 words
A composition as claimed in claim 9 wherein said compound is 9-fluoro-10-(4-aminosulfonylphenyl)-3-methyl-7-oxo-2,3-dihydro-(7H)-pyrido-(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid.
Claim 14
Dependent Claim 29 words
A method for treating a host infected by a bacterial disease which comprises administering to said host an antibacterially effective amount of a compound as claimed in claim 1.
Claim 15
Dependent Claim 13 words
A compound according to claim 1 wherein said compound is 6-fluoro-7-(4-hydroxyphenyl)-1-(4-fluorophenyl)-1,4-dihydroquinol-4-one 3-carboxylic acid.
Claim 16
Dependent Claim 13 words
A composition according to claim 9 wherein said compound is 6-fluoro-7-(4-hydroxyphenyl)-1-(4-fluorophenyl)-1,4-dihydroquinol-4-one 3-carboxylic acid.
Claim 17
Dependent Claim 52 words
A composition for the treatment of St. aureus which comprises 6-fluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid or 6,8-difluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid wherein Y is alkyl, haloalkyl or polyhaloalkyl of 1 to 3 carbon atoms, hydroxyethyl, cyclopropyl, vinyl, allyl, phenyl, 4-hyroxyphenyl or 4-fluorphenyl, in an amount sufficient for treatment of St. aureus, and a pharmaceutically acceptable carrier.
Claim 18
Dependent Claim 52 words
A composition for the treatment of St. aureus which comprises 6-fluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid or 6,8-difluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid wherein Y is alkyl, haloalkyl or polyhaloalkyl of 1 to 3 carbon atoms, hydroxyethyl, cyclopropyl, vinyl, allyl, phenyl, 4-hyroxyphenyl or 4-fluorphenyl, in an amount sufficient for treatment of St. aureus, and a pharmaceutically acceptable carrier.
Claim 19
Independent Claim 53 words
A method for treating a host infected by St. aureus which comprises administering to said host 6-fluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid or 6,8-difluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid wherein Y is alkyl, haloalkyl or polyhaloalkyl of 1 to 3 carbon atoms, hydroxyethyl, cyclopropyl, vinyl, allyl, phenyl, 4-hydroxyphenyl or 4-fluorophenyl in an amount sufficient for treatment of St. aureus.
Claim 20
Independent Claim 53 words
A method for treating a host infected by St. aureus which comprises administering to said host 6-fluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid or 6,8-difluoro-7-phenyl-1-Y-1,4-dihydroquinol-4-one 3-carboxylic acid wherein Y is alkyl, haloalkyl or polyhaloalkyl of 1 to 3 carbon atoms, hydroxyethyl, cyclopropyl, vinyl, allyl, phenyl, 4-hydroxyphenyl or 4-fluorophenyl in an amount sufficient for treatment of St. aureus.

References Cited (Backward Citations)

US3472859A Cited
US3907808A Cited
US4398029A Cited
US4398029B1 Cited
US4443447A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-11-17 1990-05-19 1990-11-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-11-17 1994-05-19 1994-11-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-11-17 1998-05-19 1998-11-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag